The START Center for Cancer Research has dosed the first [...]

Kaerus Bioscience has been granted Orphan Drug Designation and Rare [...]

The US Food and Drug Administration (FDA) has announced plans [...]

Vesper Bio has reached a key enrolment milestone in its [...]

Company says dual-acting oral therapy improves bile acid transport and [...]

New non-GMP Line 0 offering is designed to give customers [...]

BioAscent has appointed seasoned drug discovery executive Dr James Hitchin [...]

Elsevier has announced the addition of over 500,000 clinical trial [...]